These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7984280)

  • 1. Differential effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on various 5-HT receptor binding sites in the rat brain.
    Gozlan H; Laporte AM; Thibault S; Schechter LE; Bolaños F; Hamon M
    Neuropharmacology; 1994; 33(3-4):423-31. PubMed ID: 7984280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) administration for studies of 5-HT1A receptor binding site inactivation and turnover.
    Keck BJ; Lakoski JM
    Brain Res Brain Res Protoc; 1997 Oct; 1(4):364-70. PubMed ID: 9384817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential protection and recovery of 5-HT1A receptors from N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) inactivation in regions of rat brain.
    Vinod KY; Subhash MN; Srinivas BN
    Neurochem Res; 2001 Feb; 26(2):113-20. PubMed ID: 11478737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline studies on the role of 5-HT1A and 5-HT2 receptors in mediating foot-shock-induced ultrasonic vocalisation in adult rats.
    Sánchez C; Mørk A
    Eur Neuropsychopharmacol; 1999 Jun; 9(4):287-94. PubMed ID: 10422888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo estimates of efficacy at 5-HT1A receptors: effects of EEDQ on the ability of agonists to produce lower-lip retraction in rats.
    Koek W; Assié MB; Zernig G; France CP
    Psychopharmacology (Berl); 2000 May; 149(4):377-87. PubMed ID: 10867965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional heterogeneity of serotonin(1A) receptor inactivation and turnover in the aging female rat brain following EEDQ.
    Keck BJ; Lakoski JM
    Neuropharmacology; 2000 Apr; 39(7):1237-46. PubMed ID: 10760365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo EEDQ dose-dependently inactivates rat brain 5-HT receptors but not 5-HT uptake sites.
    Pinto W; Battaglia G
    Neuroreport; 1993 Oct; 5(1):61-4. PubMed ID: 8280861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of 5-HT1A and [3H]5-HT binding sites by N-ethoxycarbonyl-2-ethoxy-1, 2-dihydroquinoline (EEDQ) in rat brain.
    Subhash MN; Srinivas BN; Vinod KY; Jagadeesh S
    Neurochem Res; 1998 Oct; 23(10):1321-6. PubMed ID: 9804289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional variability in changes in 5-HT2A receptor mRNA levels in rat brain following irreversible inactivation with EEDQ.
    Raghupathi RK; Artymyshyn R; McGonigle P
    Brain Res Mol Brain Res; 1996 Jul; 39(1-2):198-206. PubMed ID: 8804728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of apparent receptor reserve at postsynaptic 5-hydroxytryptamine1A receptors negatively coupled to adenylyl cyclase activity in rat hippocampal membranes.
    Yocca FD; Iben L; Meller E
    Mol Pharmacol; 1992 Jun; 41(6):1066-72. PubMed ID: 1352034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes.
    Gozlan H; Thibault S; Laporte AM; Lima L; Hamon M
    Eur J Pharmacol; 1995 Jan; 288(2):173-86. PubMed ID: 7720779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of 5-HT(1A) receptors in hippocampal and cortical homogenates.
    Alper RH; Nelson DL
    Eur J Pharmacol; 2000 Feb; 390(1-2):67-73. PubMed ID: 10708708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The (S)-isomer of [3H]zacopride labels 5-HT3 receptors with high affinity in rat brain.
    Waeber C; Pinkus LM; Palacios JM
    Eur J Pharmacol; 1990 Jun; 181(3):283-7. PubMed ID: 2384135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Region-specific serotonin1A receptor turnover following irreversible blockade with EEDQ.
    Keck BJ; Lakoski JM
    Neuroreport; 1996 Nov; 7(15-17):2717-21. PubMed ID: 8981454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-course of recovery of 5-HT1A receptors and changes in 5-HT1A receptor mRNA after irreversible inactivation with EEDQ.
    Raghupathi RK; Brousseau DA; McGonigle P
    Brain Res Mol Brain Res; 1996 Jun; 38(2):233-42. PubMed ID: 8793111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
    Meller E; Goldstein M; Bohmaker K
    Mol Pharmacol; 1990 Feb; 37(2):231-7. PubMed ID: 1968223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of gamma-aminobutyric acidA receptor binding and function by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vitro and in vivo: effects of aging.
    Miller LG; Lumpkin M; Galpern WR; Greenblatt DJ; Shader RI
    J Neurochem; 1991 Apr; 56(4):1241-7. PubMed ID: 1848276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irreversible antagonism of 5HT2c receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).
    Ni YG; Camacho N; Miledi R
    Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2715-8. PubMed ID: 9122262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of the peptide-coupling agent, EEDQ, on 5-HT2A receptor binding and function in rat frontal cortex.
    Kettle CJ; Cheetham SC; Martin KF; Prow MR; Heal DJ
    Neuropharmacology; 1999 Sep; 38(9):1421-30. PubMed ID: 10471096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facilitation by 8-OH-DPAT of passive avoidance performance in rats after inactivation of 5-HT(1A) receptors.
    Otano A; García-Osta A; Ballaz S; Frechilla D; Del Río J
    Br J Pharmacol; 1999 Dec; 128(8):1691-8. PubMed ID: 10588924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.